Abstract
Aim:
To develop probes for detecting the binding specificity between β-secretase and substrate, and provide reliable biological activity data for further researching encircling substrate-based inhibitors.
Methods:
To prepare the inhibitors, the hydroxyethylene (HE) segment including P1 and P1′ was synthesized after multi-step reactions; the combination of all segments was then completed through solid phase synthesis. Recombinant human β-secretase ectodomain (amino acid residues 1-460) was expressed as a secreted protein with a C-terminal His tag in insect cells using baculovirus infection, and all compounds were evaluated in this β-secretase enzyme assay. In order to understand the interaction in detail, the theoretical methods, namely molecular dynamics (MD) simulation and molecular mechanics-generalized-born surface area (MM-GBSA) analysis, were performed on the complex of β-secretase and OM99-2 to obtain the geometrical and energetical information.
Results:
We designed and constructed a positional scanning combinatorial library including 16 compounds; all members of the library were synthesized based on HE dipeptide isostere. Structure-activity relationship studies at the P4-P1 and P1′-P4′ positions led to the discoveries of P and P′ sides binding specificity and potent inhibitors 14, 18, and 22. The binding free energy on the whole system and every residue were compared to the biological assay result.
Conclusion:
The removal of P4′ yielded inhibitor 22 (A3*B2) with high potency; further truncation of P3′ gave inhibitor 18 (A3*B1) with equal activity, implying that the right side of the inhibitors play a less important role and could be easily simplified, while change on the P side may cause substantial results.
Similar content being viewed by others
Article PDF
References
VanDenBerg CM, Kazmi Y, Jann MW . Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly. Drugs Aging 2000; 16: 123–38.
Selkoe DJ . Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 1999; 399A: 23.
Hong L, Koelsch G, Lin XL, Wu SL, Terzyan S, Ghosh AK, et al. Structure of the protease domain of memapsin 2 (β-secretase) complexed with inhibitor. Science 2000; 290: 150–3.
Selkoe DJ . Alzheimer's disease: genes, proteins and therapy. Physiol Rev 2001; 81: 741–66.
Vassar R, Citron M . Aβ-generating enzymes: recent advances in β- and β-secretase research. Neuron 2000; 27: 419–22.
Hu JD, Cwi CL, Smiley DL, Timm D, Erickson JA, McGee JE, et al. Design and synthesis of statine-containing BACE-inhibitors. Bioorg Med Chem Lett 2003; 13: 4335–9.
Tung JS, Davis DL, Anderson JP, Walker DE, Mamo S, Jewett N, et al. Design of substrate-based inhibitors of human β-secretase. J Med Chem 2002; 45: 259–62.
Vmezawa H, Agoyagi T, Morishima H, Matzusaki M, Hamada H, Takeuchi T . Pepstatin, a new pepsin inhibitor produced by actinomycetes. J Antibiot 1970; 23: 259–62.
Hom RK, Gailunas AF, Mamo S, Fang LY, Tung JS, Walker DE, et al. Design and synthesis of hydroxyethylene-based peptidomimetic inhibitors of human β-secretase. J Med Chem 2004; 47: 158–64.
Ghosh AK, Bilcer G, Harwood C, Kawahama R, Shin D, Hussain KA, et al. Structure-based design: potent inhibitors of human brain memapsin 2 (β-secretase). J Med Chem 2001; 44: 2865–8.
Tamamura H, Kato T, Otaka A, Fujii N . Synthesis of potent β-secretase inhibitors containing a hydroxyethylamine dipeptide isostere and their structure-activity relationship studies. Org Biomol Chem 2003; 1: 2468–73.
Wang W, Donini O, Reyes CM, Kollman PA . Biomolecular simulations: recent developments in force fields, simulations of enzyme catalysis, protein-ligand, protein-protein, and protein-nucleic acid noncovalent interactions. Annu Rev Biophys Biomol Struct 2001; 30: 211–43.
Zeng J, Treutlein HR, Simonson T . Molecular dynamics simulations of the Ras:Raf and Rap:Raf complexes. Proteins 1999; 35: 89–100.
Reyes CM, Kollman PA . Structure and thermodynamics of RNA-protein binding: using molecular dynamics and free energy analyses to calculate the free energies of binding and conformational change. J Mol Biol 2000; 297: 1145–58.
Ghosh AK, Shin D, Downs D, Koelsch G, Lin XL, Ermolieff J, et al. Design of potent inhibitors for human brain memapsin 2 (β-secretase). J Am Chem Soc 2000; 122: 3522–3.
Atherton E, Sheppard RC . Solid phase peptide synthesis. Oxford, UK: Oxford University Press; p 108.
Case DA, Pearlman DA, Caldwell JW, Cheatham TEI, Wang J, Ross WS, et al. AMBER 7. San Francisco: University of California; 2002.
Ryckaert JP, Ciccotti G, Berendsen JC . Numerical integration of the Cartesian equation of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys 1977; 23: 327–41.
Berendsen HCJ, Postma JPM, van Gunsteren WF, DiNole A, Haak JR . Molecular dynamics with coupling to an external bath. J Chem Phys 1984; 81: 3684–90.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the National Natural Science Foundation of China (No 30230400 and 30200341) and the State Key Program of Basic Research of China (2004GB 518907).
Rights and permissions
About this article
Cite this article
Hu, B., Xiong, B., Qiu, By. et al. Construction of a small peptide library related to inhibitor OM99-2 and its structure-activity relationship to β-secretase. Acta Pharmacol Sin 27, 1586–1593 (2006). https://doi.org/10.1111/j.1745-7254.2006.00432.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2006.00432.x
Keywords
This article is cited by
-
Retrospective molecular docking study of WY-25105 ligand to β-secretase and bias of the three-dimensional structure flexibility
Journal of Molecular Modeling (2013)
-
Pharmacopore hypothesis generation of BACE-1 inhibitors and pharmacophore-driven identification of potent multi-target neuroprotective agents
Medicinal Chemistry Research (2012)
-
Interaction Models of Substrate Peptides and β-Secretase Studied by NMR Spectroscopy and Molecular Dynamics Simulation
Molecules and Cells (2009)